Page last updated: 2024-10-29

ketanserin and Cancer of Gastrointestinal Tract

ketanserin has been researched along with Cancer of Gastrointestinal Tract in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"Calcium infusion induced carcinoid symptoms in only two of six patients, which were associated with elevated 5-HT levels (whereas elevated SP levels were seen in only one patient)."1.27The pentagastrin test in the diagnosis of the carcinoid syndrome. ( Ahlman, H; Dahlström, A; Grönstad, K; Jaffe, BM; Nilsson, O; Oberg, K, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlman, H1
Dahlström, A1
Grönstad, K1
Jaffe, BM1
Nilsson, O1
Oberg, K1

Other Studies

1 other study available for ketanserin and Cancer of Gastrointestinal Tract

ArticleYear
The pentagastrin test in the diagnosis of the carcinoid syndrome.
    Journal of cardiovascular pharmacology, 1985, Volume: 7 Suppl 7

    Topics: Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Ketanserin; M

1985